Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?

Akbar Dorgalaleh; Ali Dabbagh; Shadi Tabibian; Mohammad Reza Baghaeipour; Mohammad Jazebi; Mehran Bahraini; Sahar Fazeli; Fariba Rad; Nazanin Baghaeipour

doi:10.1055/s-0040-1713435

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2020; 46(07): 853-855
DOI: 10.1055/s-0040-1713435

Letter to the Editor

Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?

Akbar Dorgalaleh

¹Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

,

Ali Dabbagh

²Anesthesiology Department & Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

,

Shadi Tabibian

¹Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

³Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

,

Mohammad Reza Baghaeipour

³Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

,

Mohammad Jazebi

³Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

,

Mehran Bahraini

¹Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

,

Sahar Fazeli

⁴Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

,

Fariba Rad

⁵Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran

⁶Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

,

Nazanin Baghaeipour

³Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

› Author Affiliations

Abstract

Full Text

References

References
1 Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. (JHU). Coronavirus COVID-19 Global Cases. Available at: www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 . Accessed May 18, 2020
2 Zhang J, Wang X, Jia X. et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect 2020; 26 (06) 767-772
3 Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in Diagnosis and management. AJR Am J Roentgenol 2020; 214 (06) 1280-1286
4 Long C, Xu H, Shen Q. et al. Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT?. Eur J Radiol 2020; 126: 108961
5 Cui D, Zhang A, Liu A, Hu Q. Clinical findings in a patient with haemophilia A affected by COVID-19. Haemophilia 2020; (e-pub ahead of print)
6 Girolami A, Tezza F, Scapin M, Vettore S, Casonato A. Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature. J Thromb Thrombolysis 2006; 21 (02) 175-178
7 Dorgalaleh A. Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost 2020; 46 (07) 815-818
8 Dorgalaleh A, Rashidpanah J. Blood coagulation factor XIII and factor XIII deficiency. Blood Rev 2016; 30 (06) 461-475
9 Wichmann D, Sperhake JP, Lütgehetmann M. et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med 2020; (e-pub ahead of print)
10 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (04) 844-847
11 Yang X, Yang Q, Wang Y. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost 2020; (e-pub ahead of print)
12 Larsen JB, Pasalic L, Hvas A-M. Platelets in coronavirus disease 2019. Semin Thromb Hemost 2020; 46 (07) 823-825
13 Page MJ, Pretorius E. A champion of host defense: a generic large scale cause for platelet dysfunction and depletion in infection. Semin Thromb Hemost 2020; 46 (03) 302-319
14 Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost 2013; 39 (06) 684-692
15 Thachil J, Srivastava A. SARS-2 coronavirus-associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism?. Semin Thromb Hemost 2020; 46 (07) 777-780
16 Dorgalaleh A, Fariba R. Congenital bleeding disorders. In: Congenital Bleeding Disorders: Diagnosis and Management. Berlin: Springer; 2018: 27-53